Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange

被引：6

作者：

Levy, Carol J. ^{[1
]}

Foster, Nicole C. ^{[2
]}

DuBose, Stephanie N. ^{[2
]}

Agarwal, Shivani ^{[3
]}

Lyons, Sarah K. ^{[4
]}

Peters, Anne L. ^{[5
]}

Uwaifo, Gabriel I. ^{[6
]}

DiMeglio, Linda A. ^{[7
]}

Sherr, Jennifer L. ^{[8
]}

Polsky, Sarit ^{[9
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Jaeb Ctr Hlth Res, 15310 Amberly Dr,Suite 350, Tampa, FL 33647 USA

[3] Albert Einstein Coll Med, Ctr Diabet Translat Res, Fleischer Inst Diabet & Metab, Bronx, NY 10467 USA

[4] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA

[5] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA

[6] Ochsner Med Ctr, New Orleans, LA USA

[7] Indiana Univ, Sch Med, Indianapolis, IN USA

[8] Yale Sch Med, New Haven, CT USA

[9] Barbara Davis Ctr Diabet, Aurora, CO USA

来源：

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY | 2021年 / 15卷 / 06期

关键词：

pregnancy; type; 1; diabetes; female; continuous glucose monitor; SUBCUTANEOUS INSULIN INFUSION; MULTIPLE DAILY INJECTIONS; SEVERE HYPOGLYCEMIA; WEIGHT-GAIN; METAANALYSIS; CONCEPTT; OUTCOMES; THERAPY; SMOKING;

D O I：

10.1177/1932296820972123

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: To examine changes in device use and glycemic outcomes for pregnant women from the T1D Exchange Clinic Registry between the years 2010-2013 and 2016-2018. Methods: Participant-reported device use and glycemic outcomes were compared for women aged 16-40 years who were pregnant at the time of survey completion, comparing 2010-2013 (cohort 1) and 2016-2018 (cohort 2). Hemoglobin A1c results within 30 days prior to survey completion were obtained from medical records. Results: There were 208 pregnant women out of 5,236 eligible participants completing the questionnaire in cohort 1 and 47 pregnant women out of 2,818 eligible participants completing the questionaire in cohort 2. Continuous glucose monitor (CGM) use while pregnant trended upward among cohort 2 (70% vs 37%, P =.02), while reported continuous subcutaneous insulin infusion (CSII) use while pregnant declined (76% vs 64%, P =.04). HbA1c levels trended downward (6.8% cohort 1 vs 6.5% cohort 2, P =.07). Conclusions: Self-reported CGM use while pregnant increased over the studied intervals whereas CSII use decreased. Additional evaluation of device use and the potential benefits for T1D pregnancies is needed.

引用

页码：1297 / 1302

页数：6

共 26 条

[1] Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study
Abell, Sally K.
Suen, Matthew
Pease, Anthony
Boyle, Jacqueline A.
Soldatos, Georgia
Regan, John
Wallace, Euan M.
Teede, Helena J.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (05) : 280 - 287
[2] The T1D Exchange Clinic Registry
Beck, Roy W.
Tamborlane, William V.
Bergenstal, Richard M.
Miller, Kellee M.
DuBose, Stephanie N.
Hall, Callyn A.
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12) : 4383 - 4389
[3] Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)
Bruttomesso, D.
Bonomo, M.
Costa, S.
Dal Pos, M.
Di Cianni, G.
Pellicano, F.
Vitacolonna, E.
Dodesini, A. R.
Tonutti, L.
Lapolla, A.
Di Benedetto, A.
Torlone, E.
[J]. DIABETES & METABOLISM, 2011, 37 (05) : 426 - 431
[4] Buschur E., 2000, ENDOTEXT
[5] Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2019
Cefalu, William T.
Berg, Erika Gebel
Saraco, Mindy
Petersen, Matthew P.
Uelmen, Sacha
Robinson, Shamera
[J]. DIABETES CARE, 2019, 42 : S165 - S172
[6] Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial
Feig, Denice S.
Corcoy, Rosa
Donovan, Lois E.
Murphy, Kellie E.
Barrett, Jon F. R.
Sanchez, J. Johanna
Wysocki, Tim
Ruedy, Katrina
Kollman, Craig
Tomlinson, George
Murphy, Helen R.
[J]. DIABETES CARE, 2018, 41 (12) : 2471 - 2479
[7] Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
Feig, Denice S.
Donovan, Lois E.
Corcoy, Rosa
Murphy, Kellie E.
Amiel, Stephanie A.
Hunt, Katharine F.
Asztalos, Elizabeth
Barrett, Jon F. R.
Sanchez, J. Johanna
de Leiva, Alberto
Hod, Moshe
Jovanovic, Lois
Keely, Erin
McManus, Ruth
Hutton, Eileen K.
Meek, Claire L.
Stewart, Zoe A.
Wysocki, Tim
O'Brien, Robert
Ruedy, Katrina
Kollman, Craig
Tomlinson, George
Murphy, Helen R.
[J]. LANCET, 2017, 390 (10110) : 2347 - 2359
[8] State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
Foster, Nicole C.
Beck, Roy W.
Miller, Kellee M.
Clements, Mark A.
Rickels, Michael R.
DiMeglio, Linda A.
Maahs, David M.
Tamborlane, William V.
Bergenstal, Richard
Smith, Elizabeth
Olson, Beth A.
Garg, Satish K.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (02) : 66 - 72
[9] Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus
Gabbe, SG
Holing, E
Temple, P
Brown, ZA
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (06) : 1283 - 1290
[10] Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection
Hauffe, F.
Schaefer-Graf, U. M.
Fauzan, R.
Schohe, A. L.
Scholle, D.
Sedlacek, L.
Scherer, K. A.
Klapp, C.
Ramsauer, B.
Henrich, W.
Schlembach, D.
Abou-Dakn, M.
[J]. DIABETIC MEDICINE, 2019, 36 (02) : 158 - 166

← 1 2 3 →